D'Orazio & Associates, Inc. Cue Biopharma, Inc. Transaction History

D'Orazio & Associates, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$10.86 - $17.85 $21,720 - $35,700	-2,000 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$4.7 - $9.29 $9,400 - $18,580	-2,000 Reduced 50.0%	2,000 $15,000
Q4 2018 Jan 24, 2019	SELL	$4.35 - $8.73 $17,400 - $34,920	-4,000 Reduced 50.0%	4,000 $19,000
Q2 2018 Aug 09, 2018	BUY	$10.93 - $14.48 $87,440 - $115,840	8,000 New	8,000 $95,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on D'Orazio & Associates, Inc. with notifications on news.